Literature DB >> 19350363

A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses.

Ryszard Miedzybrodzki1, Wojciech Fortuna, Beata Weber-Dabrowska, Andrzej Górski.   

Abstract

Bacteriophages are increasingly considered an alternative to antibiotics for the treatment of bacterial infections. Clinical improvement may be associated with a lowering of inflammatory markers during the antibiotic treatment of bacterial infections. Some experimental data suggest that phage treatment may have anti-inflammatory properties. We present a retrospective analysis of C-reactive protein (CRP) serum concentration, erythrocyte sedimentation rate (ESR), and white blood cell count (WBC) measured in patients with chronic, symptomatic, antibiotic therapy-resistant bacterial infections who qualified for phage treatment within the protocol "Experimental Phage Therapy of Antibiotic Therapy-Resistant Infections, Including MRSA Infections". Data collected from 37 patients with osteomyelitis (with or without metal implants or joint endoprosthesis) or skin and soft tissue or lower respiratory tract infection induced by, in the majority of cases, S. aureus were analyzed. Phage preparations (natural phage lysates) were administered orally (one 10-ml ampoule three times daily after neutralization of gastric juice with 10 ml of dihydroxyaluminium sodium carbonate) and/or locally (one ampoule two times daily for wet compresses or irrigation of a fistula). No significant changes in mean serum levels of CRP measured after 5-8 days of phage administration were observed compared with the baseline CRP levels measured before therapy (35.7 vs. baseline 38.6 mg/l, n = 11). However, a significant decrease in mean CRP values measured later, between days 9 and 32, was noted (16.1 vs. baseline 23.3 mg/l, n = 26, P < 0.05). Similar tendencies were observed in the changes in mean WBC values, but mean ESR in the patients before, in the early phase, and later during therapy did not change significantly. This is the first report suggesting that the application of phage preparations may probably influence and diminish the inflammatory reaction that accompanies bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350363     DOI: 10.1007/s10238-009-0044-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  18 in total

Review 1.  The valuable contribution of observational studies to nephrology.

Authors:  K J Jager; V S Stel; C Wanner; C Zoccali; F W Dekker
Journal:  Kidney Int       Date:  2007-06-27       Impact factor: 10.612

2.  Antibiotic-resistant bugs in the 21st century--a clinical super-challenge.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

3.  Duration of postoperative antibiotic therapy following revision for infected knee and hip arthroplasties.

Authors:  S Houshian; A S Zawadski; P Riegels-Nielsen
Journal:  Scand J Infect Dis       Date:  2000

4.  Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers.

Authors:  Kazuya Sasaki; Ichiro Fujita; Yuhei Hamasaki; Sumio Miyazaki
Journal:  J Infect Chemother       Date:  2002-03       Impact factor: 2.211

5.  Effects of bacteriophages on free radical production and phagocytic functions.

Authors:  Anna Przerwa; Michał Zimecki; Kinga Switała-Jeleń; Krystyna Dabrowska; Ewa Krawczyk; Mirosław Łuczak; Beata Weber-Dabrowska; Danuta Syper; Ryszard Miedzybrodzki; Andrzej Górski
Journal:  Med Microbiol Immunol       Date:  2006-01-31       Impact factor: 3.402

6.  Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes.

Authors:  Ryszard Miedzybrodzki; Kinga Switala-Jelen; Wojciech Fortuna; Beata Weber-Dabrowska; Anna Przerwa; Marzanna Lusiak-Szelachowska; Krystyna Dabrowska; Aneta Kurzepa; Janusz Boratynski; Danuta Syper; Gryzelda Pozniak; Czeslaw Lugowski; Andrzej Gorski
Journal:  Virus Res       Date:  2007-11-09       Impact factor: 3.303

7.  Serum C-reactive protein levels correlate with clinical response in patients treated with antibiotics for wound infections after spinal surgery.

Authors:  Mustafa H Khan; Patrick N Smith; Nalini Rao; William F Donaldson
Journal:  Spine J       Date:  2006 May-Jun       Impact factor: 4.166

8.  Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

Authors:  P Depuydt; D Benoit; D Vogelaers; J Decruyenaere; D Vandijck; G Claeys; G Verschraegen; S Blot
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

9.  Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens.

Authors:  C Ruedl; M Frühwirth; G Wick; H Wolf
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

10.  Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study.

Authors:  Dominique M Vandijck; Eric A Hoste; Stijn I Blot; Pieter O Depuydt; Renaat A Peleman; Johan M Decruyenaere
Journal:  BMC Infect Dis       Date:  2007-09-14       Impact factor: 3.090

View more
  20 in total

Review 1.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

2.  Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report.

Authors:  S Letkiewicz; R Miedzybrodzki; W Fortuna; B Weber-Dabrowska; A Górski
Journal:  Folia Microbiol (Praha)       Date:  2009-11-24       Impact factor: 2.099

3.  The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes.

Authors:  Ewa Jończyk-Matysiak; Marzanna Łusiak-Szelachowska; Marlena Kłak; Barbara Bubak; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Maciej Żaczek; Wojciech Fortuna; Paweł Rogóż; Sławomir Letkiewicz; Krzysztof Szufnarowski; Andrzej Górski
Journal:  J Immunol Res       Date:  2015-12-09       Impact factor: 4.818

Review 4.  Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases.

Authors:  Andrzej Górski; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Wojciech Fortuna; Sławomir Letkiewicz; Paweł Rogóż; Ewa Jończyk-Matysiak; Krystyna Dąbrowska; Joanna Majewska; Jan Borysowski
Journal:  Front Microbiol       Date:  2016-09-26       Impact factor: 5.640

5.  Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy.

Authors:  Maciej Żaczek; Marzanna Łusiak-Szelachowska; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Ryszard Międzybrodzki; Barbara Owczarek; Agnieszka Kopciuch; Wojciech Fortuna; Paweł Rogóż; Andrzej Górski
Journal:  Front Microbiol       Date:  2016-10-24       Impact factor: 5.640

6.  Efficacy and Safety of a Bovine-Associated Staphylococcus aureus Phage Cocktail in a Murine Model of Mastitis.

Authors:  Koen Breyne; Ryan W Honaker; Zachary Hobbs; Manuela Richter; Maciej Żaczek; Taylor Spangler; Jonas Steenbrugge; Rebecca Lu; Anika Kinkhabwala; Bruno Marchon; Evelyne Meyer; Lucia Mokres
Journal:  Front Microbiol       Date:  2017-11-28       Impact factor: 5.640

Review 7.  Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.

Authors:  Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Barbara Owczarek; Ryszard Międzybrodzki; Marzanna Łusiak-Szelachowska; Norbert Łodej; Andrzej Górski
Journal:  Viruses       Date:  2017-06-14       Impact factor: 5.048

Review 8.  Therapeutic potential of phages in autoimmune liver diseases.

Authors:  A Górski; E Jończyk-Matysiak; M Łusiak-Szelachowska; B Weber-Dąbrowska; R Międzybrodzki; J Borysowski
Journal:  Clin Exp Immunol       Date:  2018-01-23       Impact factor: 4.330

Review 9.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

Review 10.  A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Authors:  Xavier Wittebole; Sophie De Roock; Steven M Opal
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.